SCOPUS 정보 검색 플랫폼

Revue Medicale de Liege

Volumn 56, Issue 6, 2001, Pages 456-459

Repaglinide;Pharma-clinics. Le médicament du mois. Le répaglinide (NovoNorm®)

(1) Scheen, A J a

a CHU SART TILMAN (Belgium)

Author keywords

Insulin secretion; Meglitinide; Postprandial hyperglycaemia; Repaglinide; Type 2 diabetes

Indexed keywords

BIGUANIDE; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; REPAGLINIDE; SULFONYLUREA DERIVATIVE;

CLINICAL PROTOCOL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN LIKE ACTIVITY; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; TABLET;

ADMINISTRATION, ORAL; CARBAMATES; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPOGLYCEMIC AGENTS; PIPERIDINES; POSTPRANDIAL PERIOD;

EID: 0034925035 PISSN: 00353663 EISSN: None Source Type: Journal
DOI: None Document Type: Review

Times cited : (7)

References (17)

1
- 0023950957
- Etiopathogénie, physiopathologie et principes généaux du traitement du diabète de type 2
- (1988) Rev Med Liège , vol.43 , pp. 205-211
- Scheen, A.¹ Lefèbvre, P.²

2
- 0032811779
- Glucotoxicité et lipotoxicité, deux complices impliqués dans le cercle vicieux du diabète de type 2
- (1999) Rev Med Liège , vol.54 , pp. 535-538
- Scheen, A.J.¹ Paquot, N.² Lefèbvre, P.J.³

3
- 0031616693
- Le syndrome X, à la croisée des maladies métaboliques et cardio-vasculaires
- (1998) Rev Med Liège , vol.53 , pp. 29-32
- Scheen, A.J.¹

4
- 0032590223
- Le diabète de type 2: Approches diagnostiques, objectifs glycémiques et stratégies thérapeutiques
- (1999) Rev Med Liège , vol.54 , pp. 659-666
- Scheen, A.J.¹ Paquot, N.²

5
- 0031939899
- Antidiabetic oral drugs: A guide to selection
- (1998) Drugs , vol.55 , pp. 225-236
- Scheen, A.J.¹ Lefèbvre, P.J.²

6
- 0026045459
- La cellule B dans le diabète de type 2: Coupable ou victime?
- Flammarion Médecine-Sciences Paris
- Journées annuelles de Diabétologie de l 'Hôtel-Dieu 1991 , pp. 153-169
- Scheen, A.J.¹ Paquot, N.² Lefèbvre, P.J.³

7
- 0033146716
- Glucose metabolism and the postprandial state
- (1999) Eur J Clin Invest , vol.29 , pp. 1-6
- Lefèbvre, P.J.¹ Scheen, A.J.²

8
- 0031794823
- The postprandial state and risk of cardiovascular disease
- (1998) Diabetic Med , vol.15
- Lefèbvre, P.J.¹ Scheen, A.J.²

9
- 0029716263
- Les sulfamidés hypoglycémiants, 50 ans après Loubatières
- (1996) Rev Med Liège , vol.51 , pp. 90-93
- Scheen, A.J.¹

10
- 0030826933
- Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s: Achievements and future developments
- (1997) Drugs , vol.54 , pp. 355-368
- Scheen, A.J.¹

11
- 0031726609
- Repaglinide, a novel, short-acting hypoglycemic agent for type 2 diabetes mellitus
- (1998) Pharmacotherapy , vol.18 , pp. 1195-1204
- Guay, D.R.¹

12
- 0031790685
- Repaglinide - Prandial glucose regulator: A new class of oral antidiabetic drug
- (1998) Diabetic Med , vol.15 , Issue.SUPPL. 4
- Owens, D.R.¹

13
- 0032790119
- Flexible prandial glucose regulation with repaglinide in patients with type 2 diabetes
- (1999) Diabes Res Clin Pract , vol.45 , pp. 31-39
- Damsbo, P.¹ Marbury, T.C.² Hatorp, V.³

14
- 0035132989
- Flexible meal-related dosing with repaglinide facilitates glycemic control in therapy-naive type 2 diabetes
- (2001) Diabetes Care , vol.24 , pp. 11-15
- Moses, R.G.¹ Gomis, R.² Brown Frandsen, K.³

15
- 0034107980
- Pharmacology and clinical experience with repaglinide
- (2000) Exp Opin Invest Drugs , vol.9 , pp. 885-898
- Massi-Benedetti, M.¹ Damsbo, P.²

16
- 0034572838
- A review of clinical experience with the prandial regulator, repaglinide, in the treatment of type 2 diabetes
- (2000) Exp Opin Pharmacother , vol.1 , pp. 1455-1467
- Moses, R.¹

17
- 0033799522
- Prandial glucose regulation with repaglinide: Its clinical and lifestyle impact in a large cohort of patients with type 2 diabetes
- (2000) Int J Obesity , vol.24 , Issue.SUPPL. 3
- Landgraf, R.¹ Frank, M.² Bauer, C.³ Leyck Dieken, M.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.